欧洲疟疾治疗市场预测至 2030 年 - 区域分析 - 按治疗(仿制药、原创药、疫苗等)、给药途径(口服和肠外给药)和分销渠道(直接招标、医院药房、零售药房、网上药房等)

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030


No. of Pages: 87    |    Report Code: TIPRE00025038    |    Category: Life Sciences

Europe Malaria Treatment Market
2022 年欧洲疟疾治疗市场价值为 4.5169 亿美元,预计到 2030 年将达到 30.6097 亿美元;预计 2022 年至 2030 年的复合年增长率为 27.0%。

新药和疫苗的不断涌现推动欧洲疟疾治疗市场的发展

抗菌素耐药性会使公众面临多种疾病的风险,例如疟疾。为了克服这一挑战,新药的研发被认为是最佳策略;因此,抗疟药物研发渠道正变得越来越强大。公私合作伙伴关系正在加速与疟疾治疗相关的研究活动。例如,非营利组织“疟疾药物研发基金会”(MMV)与众多制药公司合作,通过开发新的治疗方案来减轻疟疾负担。

下表列出了一些正在进行临床开发的抗疟药物:

表 1. 正在进行临床开发的抗疟药物/疫苗/化合物

药物开发商临床试验阶段

Artefenomel 赛诺菲 IIb 期

KAE609 诺华公司 IIb 期

KAF156 诺华公司 IIb 期

DSM265 武田制药公司 IIa 期

SANARIA PfSPZ-GA1 Sanaria II 期

SANARIA PfSPZ 疫苗 - 辐射减毒 PfSPZ 疫苗 Sanaria II 期

SANARIA PfSPZ-CVac Sanaria II 期

MSP3-CRM-Vac4All Vac4All I 期

肝阶段抗原 3 (LSA3) Vac4All IIa 期

来源:公司网站,Insight Partners 分析

因此,抗疟和正在临床开发的药物/疫苗有望在未来推动市场增长。

欧洲疟疾治疗市场概况

根据 ECDC 的监测报告,法国报告的疟疾病例数在 2020 年最多。2020 年,法国报告了 1,007 例确诊疟疾病例。2020 年,欧盟/欧洲经济区国家报告的几乎所有病例都是在从其他国家前往法国的旅行者中确诊的;这些病例大多与西非的旅行路线有关。在法国,恶性疟原虫是几乎所有旅行者重症病例和死亡的罪魁祸首。许多研究机构正在努力开发新方法来消除法国的疟疾。例如,巴斯德研究所的团队致力于疟疾研究,旨在开发疫苗。这项研究对于寻找抗击疟疾的新方法至关重要。巴斯德研究所还参加了一项名为 EVIMalaR 的欧洲重大计划,该计划涉及来自 7 个欧洲国家的 17 个研究机构和大学,以及来自 3 个非洲国家的合作伙伴。这种为消除疟疾而开展的合作努力正在推动法国疟疾治疗市场的增长。

欧洲疟疾治疗市场收入及 2030 年预测(百万美元)

欧洲疟疾治疗市场细分

欧洲疟疾治疗市场根据治疗、给药途径、分销渠道和国家进行细分。根据治疗方法,欧洲疟疾治疗市场细分为仿制药、原研药、疫苗和其他。仿制药部分在 2022 年占据了最大的市场份额。

就给药途径而言,欧洲疟疾治疗市场分为口服和肠外给药。口服部分在 2022 年占据了更大的市场份额。

按分销渠道,欧洲疟疾治疗市场细分为直接招标、医院药房、零售药房、网上药房和其他。 2022 年,直接招标部分占据了最大的市场份额。

根据国家/地区,欧洲疟疾治疗市场分为英国、德国、法国、意大利、西班牙和欧洲其他地区。2022 年,法国占据了欧洲疟疾治疗市场份额的主导地位。

Cipla Ltd、Sun Pharmaceutical Industries Ltd、Sanofi SA、GSK Plc、Novartis AG、Pfizer Inc 和 Lupin Ltd 是欧洲疟疾治疗市场的一些领先参与者。

Europe Malaria Treatment Strategic Insights

Strategic insights for Europe Malaria Treatment involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/europe-malaria-treatment-market-strategic-framework.webp
Get more information on this report

Europe Malaria Treatment Report Scope

Report Attribute Details
Market size in 2022 US$ 451.69 Million
Market Size by 2030 US$ 3,060.97 Million
Global CAGR (2022 - 2030) 27.0%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By 治疗
  • 仿制药
  • 原创药物
  • 疫苗
By 给药途径
  • 口服
  • 肠胃外
By 分销渠道
  • 直接招标
  • 医院药房
  • 零售药房
  • 网上药房
Regions and Countries Covered 欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
Market leaders and key company profiles
  • Cipla Ltd
  • Sun Pharmaceutical Industries Ltd
  • Sanofi SA
  • GSK Plc
  • Novartis AG
  • Pfizer Inc
  • Lupin Ltd
  • Get more information on this report

    Europe Malaria Treatment Regional Insights

    The regional scope of Europe Malaria Treatment refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/europe-malaria-treatment-market-geography.webp
    Get more information on this report

    The List of Companies - Europe Malaria Treatment Market

    1. Cipla Ltd
    2. Sun Pharmaceutical Industries Ltd
    3. Sanofi SA
    4. GSK Plc
    5. Novartis AG
    6. Pfizer Inc
    7. Lupin Ltd

    Frequently Asked Questions
    How big is the Europe Malaria Treatment Market?

    The Europe Malaria Treatment Market is valued at US$ 451.69 Million in 2022, it is projected to reach US$ 3,060.97 Million by 2030.

    What is the CAGR for Europe Malaria Treatment Market by (2022 - 2030)?

    As per our report Europe Malaria Treatment Market, the market size is valued at US$ 451.69 Million in 2022, projecting it to reach US$ 3,060.97 Million by 2030. This translates to a CAGR of approximately 27.0% during the forecast period.

    What segments are covered in this report?

    The Europe Malaria Treatment Market report typically cover these key segments-

  • 治疗 (仿制药, 原创药物, 疫苗)
  • 给药途径 (口服, 肠胃外)
  • 分销渠道 (直接招标, 医院药房, 零售药房, 网上药房)
  • What is the historic period, base year, and forecast period taken for Europe Malaria Treatment Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Malaria Treatment Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
  • Who are the major players in Europe Malaria Treatment Market?

    The Europe Malaria Treatment Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Cipla Ltd
  • Sun Pharmaceutical Industries Ltd
  • Sanofi SA
  • GSK Plc
  • Novartis AG
  • Pfizer Inc
  • Lupin Ltd
  • Who should buy this report?

    The Europe Malaria Treatment Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Europe Malaria Treatment Market value chain can benefit from the information contained in a comprehensive market report.